SOUTH SAN FRANCISCO, Calif., April 24, 2023 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common stock and pre-funded warrants. IDEAYA is selling 7,439,201 shares of common stock and pre-funded warrants to purchase…
